Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000121187 | SCV000613608 | benign | not specified | 2017-02-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000864048 | SCV001004794 | benign | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002326821 | SCV002601690 | benign | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs146686581 with MODY3. | |
KCCC/NGS Laboratory, |
RCV003315758 | SCV004015764 | benign | Nonpapillary renal cell carcinoma | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002326821 | SCV005036118 | likely benign | Maturity onset diabetes mellitus in young | 2023-12-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ITMI | RCV000121187 | SCV000085356 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |